Holen Sie sich die Stockscreener-App
1.405
9.37%
0.125
Schlusskurs vom Vortag:
$1.28
Offen:
$1.31
24-Stunden-Volumen:
536.58K
Relative Volume:
1.02
Marktkapitalisierung:
$112.07M
Einnahmen:
$2.43M
Nettoeinkommen (Verlust:
$-52.67M
KGV:
-1.1151
EPS:
-1.26
Netto-Cashflow:
$-33.04M
1W Leistung:
+0.72%
1M Leistung:
-4.11%
6M Leistung:
+65.45%
1J Leistung:
+25.00%
1-Tages-Spanne:
$1.29
$1.4201
1-Wochen-Bereich:
$1.18
$1.40
52-Wochen-Spanne:
$0.6301
$1.633
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Firmenname
Lucid Diagnostics Inc
Sektor
Branche
Telefon
212 949 4319
Adresse
360 MADISON AVENUE, NEW YORK
Vergleichen Sie LUCD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.4091 | 112.07M | 2.43M | -52.67M | -33.04M | -1.26 |
|
ABT
Abbott Laboratories
|
126.18 | 221.85B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
97.13 | 142.24B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
370.29 | 140.07B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
93.11 | 118.98B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.74 | 40.31B | 5.72B | 4.17B | 259.90M | 6.97 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-12-27 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2021-11-08 | Eingeleitet | BTIG Research | Buy |
| 2021-11-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-11-08 | Eingeleitet | Needham | Buy |
Lucid Diagnostics Inc Aktie (LUCD) Neueste Nachrichten
Blue Cross Blue Shield backs esophageal cancer DNA test - Investing.com India
Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA Test - PR Newswire
Lucid Diagnostics Executes First Concierge Medicine Contract wit - GuruFocus.com
Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Pri - GuruFocus.com
PAVmed CEO to Reveal Growth Strategy and Q4 Results in Upcoming Investor Call - StockTitan
Lucid Diagnostics (NASDAQ:LUCD) Trading Down 14.4% – Here’s Why - Defense World
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025 - BioSpace
Analyzing Embecta (NASDAQ:EMBC) and Lucid Diagnostics (NASDAQ:LUCD) - Defense World
Understanding Lucid Diagnostics Inc (NASDAQ: LUCD)’s Growth Potential - Stocks Register
Midtown company tells investors esophageal pre-cancer screening should be an easier pill to swallow - Crain's New York Business
Lucid Diagnostics secures $15.3 million in stock offering By Investing.com - Investing.com Australia
Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering - GuruFocus.com
Lucid Diagnostics secures $15.3 million in stock offering - Investing.com India
Lucid Diagnostics Raises $15.3 Million in Stock Offering - TipRanks
Lucid Diagnostics secures $15.3 million in stock sale By Investing.com - Investing.com Australia
Lucid Diagnostics Announces $15.3 Million Registered Direct Offering - The Eastern Progress Online
SEC Form 424B5 filed by Lucid Diagnostics Inc. - Quantisnow
Lucid Diagnostics announces registered direct offering - Medical Buyer
Lucid Diagnostics Announces $15.3 Million Registered Direct Offe - GuruFocus.com
Lucid Diagnostics Announces $15.3 Mln Direct Offering - Nasdaq
Lucid Diagnostics ends "at the market" equity offering By Investing.com - Investing.com South Africa
Lucid Diagnostics stock dips on $15.3M share offering - MSN
Lucid Diagnostics secures $15.3 million in stock sale - Investing.com India
Lucid Diagnostics Prices $15.3 Million Direct Offering -March 04, 2025 at 09:03 am EST - Marketscreener.com
Lucid Diagnostics Announces $15.3 Million Direct Offering - TipRanks
Lucid Diagnostics ends "at the market" equity offering - Investing.com India
Lucid Diagnostics to sell 13.94M shares at $1.10 in registered direct offering - TipRanks
Lucid Diagnostics Raises $15.3 Million Through Common Stock Offering at $1.10 Per Share - StockTitan
Can Lucid's Cancer Test Reach Millions More Patients? NIH Invests $8M to Find Out - StockTitan
Renowned Investigators Awarded $8 Million NIH Grant to Study Luc - GuruFocus.com
Lucid Diagnostics meets Nasdaq minimum bid price rule By Investing.com - Investing.com Australia
Lucid Diagnostics Restores Nasdaq Listing Compliance - Nasdaq
Lucid Diagnostics regains compliance with Nasdaq listing requirement - MSN
Lucid Diagnostics meets Nasdaq minimum bid price rule - Investing.com
Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement - PR Newswire
Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health -February 20, 2025 at 08:31 am EST - Marketscreener.com
Lucid Diagnostics secures concierge medicine contract By Investing.com - Investing.com Nigeria
LUCDLucid Diagnostics Inc. Latest Stock News & Market Updates - StockTitan
Lucid Diagnostics secures concierge medicine contract - Investing.com
Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health - Nasdaq
PAVmed regains compliance with Nasdaq Capital Market’s CLS - Medical Buyer
PAVMPavmed Latest Stock News & Market Updates - StockTitan
Innovative Tech Company Surges Forward: PAVmed Triumphs in Nasdaq Compliance - Smartphone Magazine
Navigating the High Seas of Market Compliance: PAVmed’s Resilient Return - Mi Valle
PAVmed Triumphs on Nasdaq: A Medical Tech Comeback Story - Jomfruland.net
Critical Victory: PAVmed's Strategic Moves Save Nasdaq StatusFull Details Inside - StockTitan
SI-BONE (NASDAQ:SIBN) vs. Lucid Diagnostics (NASDAQ:LUCD) Head to Head Survey - Defense World
Lucid Diagnostics stock hits 52-week high at $1.5 amid growth optimism - MSN
Lucid Diagnostics (NASDAQ:LUCD) vs. Insulet (NASDAQ:PODD) Head-To-Head Review - Defense World
Finanzdaten der Lucid Diagnostics Inc-Aktie (LUCD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.57%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):